Work

Supplementary Figure S1 from Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

Year: 2023

Type: supplementary-materials

Abstract: Ten-year survival of clear-cell renal cell cancer patients from the population-based series according to CDO1 methylation in patients A) aged {greater than or equal to}55 to <65 years, B) aged {greater than or equal to} 65 to <75 years and C) aged {greater than or equal to}75 years at diagnosis.

DOI: 10.1158/1078-0432.22455860.v1

Authors: Ivette A.G. Deckers, Leo J. Schouten, Leander Van Neste, Iris J.H. van Vlodrop, Patricia M.M.B. Soetekouw, Marcella M.L.L. Baldewijns, Jana Jeschke, Nita Ahuja, James G. Herman, Piet A. van den Brandt, Manon van Engeland

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361911264

Cites:

Cited by:

Related to: 10